Gain Therapeutics Inc.

NASDAQ: GANX · Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT

Gain Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-5.81M -4.53M -3.77M -4.49M -8.14M -4.01M -4.72M -4.72M -7.69M -5.14M -4.67M -4.56M -5.09M -3.27M -3.22M -4.66M -3.56M -2.45M
Depreciation & Amortization
22.33K 20.66K 21.31K 21.64K 20.59K 20.53K 23.59K 20.51K 20.24K 19.24K 18.11K 17.83K 20.02K 8.21K 5.79K 4.13K 2.16K 3.4K
Stock-Based Compensation
522.02K 419.5K 359.33K 357.5K 1.48M 190.42K 555.06K 907.33K 1.23M 565.43K 558.69K 355.65K 305.55K 306.55K 286.26K 250.82K 191.56K 110.72K
Other Working Capital
n/a -955.36K -562.96K -71.81K -433.73K -286.79K -402.57K 40.92K 2.05M -600.1K 800.87K 630.92K 96.11K -1.08M -98.44K -22.59K 193.89K -38.16K
Other Non-Cash Items
9.25M 109.59K 553.98K -44.18K -166.13K -200.15K 1.44M -171.11K 45.85K -122.24K -140.97K -35.84K -76.35K 46.3K -7.08K -20.24K 337.85K 21.86K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -1.58M n/a n/a n/a n/a n/a n/a n/a 227.66K 517K n/a n/a
Change in Working Capital
-158.78K 158.78K -621.03K -1.93M 1.05M 416.81K -1.38M -5.18K 1.37M 457.47K 334.02K 931.5K -214.86K 464.2K -1.44M 1.72M -191.93K -473.59K
Operating Cash Flow
3.82M -3.82M -3.45M -6.08M -5.76M -3.59M -5.66M -3.97M -5.02M -4.22M -3.9M -3.29M -5.05M -2.45M -4.15M -2.19M -3.22M -2.81M
Capital Expenditures
n/a n/a -945 n/a -21.55K 3.00 -19 -650 -3.64K -11.04K -9.4K -57.18K -44.55K -7.83K -11.1K -32.12K -22.5K -28.49K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1M -1M n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.96M -1.93M -959.18K -14.84M n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a -42.5K n/a 2.02M 3.02M 3.14M 1.93M 3.05M 4.07M 2.07M 1M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1M 1M n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -43.45K n/a 2M 3.02M 3.14M 1.93M 3.05M 2.11M 133.83K -11.41K -14.89M -7.83K -11.1K -32.12K -22.5K -28.49K
Debt Repayment
n/a -22.24K -22.78K -23.12K -22.11K -22.87K -22.58K -22.63K -22.25K -21.61K -21.58K -20.58K 1.36K -37.97K -21.95K n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.47M n/a n/a 216.28K 13.57K -280.87K n/a n/a 2.22M n/a n/a n/a n/a n/a 12.22K n/a -213.79K -639.69K
Financial Cash Flow
2.47M 2.4M 2.31M 808.68K 10.04M -145.8K 9.56M 134.47K 2.2M 748.91K -21.58K -20.58K 1.36K -37.97K -9.73K n/a -213.79K 41.99M
Net Cash Flow
-2.37M -1.31M -1.67M -4.88M 6.3M -1.15M 7.52M -2.05M 332.42K -1.32M -3.57M -3.43M -20.03M -2.54M -4.1M -2.19M -3.43M 39.13M
Free Cash Flow
3.82M -3.82M -3.46M -6.08M -5.78M -3.59M -5.66M -3.97M -5.03M -4.23M -3.91M -3.35M -5.1M -2.46M -4.16M -2.22M -3.24M -2.84M